COVID-19封锁对沙特阿拉伯儿科支气管喘患者的影响:一项比较研究
Manal Bawazeer1,2,3, Aljowhara F Saad4,3, Bushra S Aljuhani4,3
1Department of Pediatrics, King Abdullah Specialized Children's Hospital, Riyadh, SAU.
Cureus
|December 17, 2024
概括
由于COVID-19的封锁,儿童的喘恶化明显减少,导致医院和急诊室的访问减少. 这表明,由于减少了环境触发因素,在疫情期间改善了喘控制.
科学领域:
- 儿科肺病学 儿科肺病学
- 环境健康 环境健康
- 流行病学 流行病学
背景情况:
- 由于COVID-19大流行,封锁可能会通过减少空气污染和交通减少喘恶化.
- 关于COVID-19封锁对儿科喘的影响的数据有限.
- 这项研究调查了封锁措施对中度至重度喘儿童的影响.
研究的目的:
- 确定COVID-19封锁对中度至重度支气管喘儿科患者的影响.
- 在封锁期间和之前分析喘严重性指标的变化.
- 在公共卫生干预的背景下,提供关于喘管理策略的见解.
主要方法:
- 在阿卜杜拉国王儿童专科医院 (KASCH),利雅得进行了回顾性横截面分析研究.
- 包括2019年3月至2020年5月期间患有中度至重度喘的儿科患者 (3-14岁).
- 评估喘的严重程度,使用住院,急诊和药物变化.
主要成果:
- 总共分析了343名儿科喘患者.
- 住院病例从2019年的46人 (85%) 减少到2020年的17人 (32%).
- 紧急病房访问显著减少 (p < 0.001),平均从1.6±1.3下降到0.6 ±0.7.7.
- 口服类固醇的使用量在2020年从28%下降到15%.
结论:
- COVID-19封锁对儿科喘产生了积极影响,由减少住院治疗,急诊室访问和口服类固醇使用所证明.
- 研究结果表明,在封锁期间,喘的严重程度有所降低.
- 建议采取全面的流行后方法来改善喘管理,包括提高意识和减少环境触发因素.
相关概念视频
Asthma-I: Introduction
2.6K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.6K
Antiasthma Drugs: β2-Adrenoceptor Agonists
232
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
232
Asthma-III: Symptoms and Complications
2.5K
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Classification of Asthma
2.5K
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics
230
Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by...
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by...
230
Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
Pulmonary Cycle: Exhalation
1.4K
In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...
1.4K


